![Show Menu](styles/mobile-menu.png)
![Page Background](./../common/page-substrates/page0116.jpg)
Institution or
National Program
Platform
Cancer(s)
Archival vs
Biopsy
Timeframe
Additional Details
Cancer Research UK
Unknown
Breast, Melanoma,
Prostate, Ovarian,
CRC, and NSCLC
Archival
4Q2011
Stratified Medicine
Program. To include
9,000 patients in 7
cancer centres across
UK.
Institut Gustav
Roussy
aCGH
Sanger
Breast, Phase I
Biopsy
Ongoing
MOSCATO (phase I;
600 patients) and
SAFIR (breast; 400
patients)
Dutch (Amsterdam,
Rotterdam, Utrecht)
Targeted exome
sequencing
(?HiSeq)
Phase I
Biopsy
Ongoing
1200 patients over 3
years with 2000
genes/patient
National or institutional molecular screening programs in breast
cancer and other advanced solid tumors predictive biomarker